0001127602-23-024071.txt : 20230913
0001127602-23-024071.hdr.sgml : 20230913
20230913162038
ACCESSION NUMBER: 0001127602-23-024071
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230911
FILED AS OF DATE: 20230913
DATE AS OF CHANGE: 20230913
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lingamneni Anila
CENTRAL INDEX KEY: 0001808414
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14041
FILM NUMBER: 231252936
MAIL ADDRESS:
STREET 1: HAEMONETICS CORPORATION
STREET 2: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HAEMONETICS CORP
CENTRAL INDEX KEY: 0000313143
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042882273
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0330
BUSINESS ADDRESS:
STREET 1: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 7818487100
MAIL ADDRESS:
STREET 1: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2023-09-11
0000313143
HAEMONETICS CORP
HAE
0001808414
Lingamneni Anila
125 SUMMER STREET
BOSTON
MA
02110
1
EVP, Chief Technology Officer
1
Common Stock
2023-09-11
4
S
0
2305
90.00
D
14495
D
Transaction pursuant to an existing 10b5-1 trading plan dated June 2, 2023 (fully executed as of June 5, 2023).
This number includes unvested restricted stock units previously reported.
/s/ Thomas V. Powers, attorney-in-fact for Ms. Lingamneni
2023-09-13